Related Experiment Video
Updated: Oct 26, 2025

Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates
Published on: February 17, 2023
Early onset congenital diarrheas; single center experience
Murat Cakir1, Elif Sag1, Burcu Guven1
1Karadeniz Technical University, Faculty of Medicine, Dept. of Pediatric Gastroenterology Hepatology and Nutrition, Turkey.
Congenital diarrheal disorders (CDDs) are rare infant enteropathies. Genetic testing significantly improved diagnosis and treatment, reducing undefined causes and improving outcomes for these challenging conditions.
Area of Science:
- Pediatric Gastroenterology
- Clinical Genetics
- Rare Diseases
Background:
- Congenital diarrheal disorders (CDDs) are rare enteropathies presenting in early infancy.
- These conditions pose significant diagnostic challenges for clinicians.
- Understanding clinical findings and outcomes is crucial for management.
Purpose of the Study:
- To analyze clinical findings and patient outcomes in infants with CDDs.
- To evaluate the utility and impact of genetic testing in diagnosing CDDs.
- To share clinical experience and insights on genetic testing for CDDs.
Main Methods:
- Retrospective analysis of demographic, clinical, and genetic data from 24 CDD patients.
- Genetic analyses included targeted gene analysis, congenital diarrhea panels, immune deficiency panels, and whole-exome sequencing.
- Patient outcomes and therapeutic consequences of genetic diagnoses were recorded.
Main Results:
- Diarrhea onset in neonatal period for 45.8% of patients.
- Common causes included defects in nutrient/electrolyte digestion, absorption, and transport (DATN) (45.8%), and intestinal immune-related homeostasis (IIH) (25%).
- Genetic diagnosis was achieved in 87.5% of tested patients, leading to therapeutic changes in 50% and a decrease in undefined etiologies.
Conclusions:
- Increased genetic testing in CDD patients reduces undefined etiologies.
- Genetic testing improves patient treatment and outcomes.
- Early diagnosis through genetic analysis is vital for managing congenital diarrheal disorders.
Related Concept Videos
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

